Farhan Abdullah, DO | Medical Director, Magnolia Functional Wellness | Southlake, TX Here's a scene I've watched play out hundreds of times
*Correspondence: Gang Liu [email protected] These authors have contributed equally to this work This article was submitted to Animal Reproduction - Theriogenology, a section of the journal Frontiers in Veterinary Science ORCID: Shubin Li orcid.org/0000-0002-6865-9667 Jingyu Ren orcid.org/0000-0002-0048-3052 Wenqi Zhang orcid.org/0000-0003-4891-500X Yanfeng Dai orcid.org/0000-0001-7147-1748 Gang Liu orcid.org/0000-0002-5180-3765 Disclaimer All claims expressed in this article are solely those of the authors and do not necessarily represent those of their affiliated organizations, or those of the publisher, the editors and the reviewers

You may not be a candidate if you have: A personal or family history of medullary thyroid carcinoma or MEN2 (GLP-1 medications) Pregnancy or breastfeeding Uncontrolled high blood pressure or significant heart disease A history of certain arrhythmias, psychiatric conditions, or substance misuse Active eating disorders or other health concerns are determined during your medical consultation Your provider will review your full health history to determine if these therapies are appropriate for you
Collectively, these advancements are reshaping treatment protocols and boosting the role of GLP-1 therapies in chronic disease management
For example, significant weight loss can disrupt the balance of estrogen and progesterone, leading to irregularities in the menstrual cycle, including changes in the frequency, duration, and intensity of menstrual periods